WIDED NAJAHI MISSAOUI

Dr. Wided Najahi Missaoui is a Clinical Assistant Professor in the Department of Pharmaceutical and Biomedical Sciences at the University of Georgia's College of Pharmacy. She holds a Pharm.D., M.S., and Ph.D. in related fields. Her research focuses on drug delivery systems, cancer pharmacology, and nanomedicine, with particular emphasis on liposomal formulations and enzyme mechanisms like ferrochelatase.

Education: Pharm.D., M.S., Ph.D. (degrees obtained from unspecified institutions).

Research Interests: Dr. Missaoui explores targeted drug delivery systems, nanoparticle safety, and the role of PAK-1 inhibition in cancer therapy. Her work spans liposomal drug design, enzymology (e.g., ferrochelatase catalysis), and oncology. Recent studies highlight advancements in prostate cancer treatment via liposomal IPA-3 delivery and the evaluation of nanomedicine risks.

Articles Trends: Her publications emphasize liposomal drug delivery optimization, nanoparticle toxicity assessment, and PAK-1 inhibition strategies in metastatic cancers. Early work also delves into ferrochelatase structure-function relationships critical to heme synthesis.

Scientific Awards: No awards explicitly listed in the provided text.

Advising & Grants: No advisees or grant details mentioned. Her research is likely supported by institutional or collaborative funding.

Labs/Teams: No specific lab or team affiliations detailed, though her work aligns with the University of Georgia's Center for Drug Discovery and Drug Discovery Group.